Cyclerion Therapeutics Inc
CYCN
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.61M
Close$
$0.58
84.6% downside
Current Fair Value
84.6% downsideOvervalued by 84.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.61 Million |
|---|---|
| Enterprise Value | $13.78 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.09 |
| Beta | 1.75 |
| Outstanding Shares | 4,205,000 |
Return
| Return on Equity | -77.69% |
|---|---|
| Return on Assets | -62.03% |
| Return on Invested Capital | -98.59% |
Valuation & Multiples
| P/E Ratio | -2.7 |
|---|---|
| PEG | -2.21 |
| Price to Sales | - |
| Price to Book Ratio | 3.76 |
| Enterprise Value to Revenue | 6.92 |
| Enterprise Value to EBIT | -2.06 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-7.10
Average shareholder expectationRevenue Estimate
$1.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.02%▼ 4.17% |
|---|---|
| Total Invested | $249,026▼ 33.81% |
| Investors Holding | 17▼ 2.00% |
ESG Score
No data